Korea United Pharm Inc. (KRX:033270)
20,450
+150 (0.74%)
Apr 24, 2026, 3:30 PM KST
Korea United Pharm Market Cap
Korea United Pharm has a market cap or net worth of 290.08 billion as of April 24, 2026. Its market cap has decreased by -0.16% in one year.
Market Cap
290.08B
Enterprise Value
n/a
Revenue
161.44B
Ranking
n/a
PE Ratio
16.10
Stock Price
20,450.00
Market Cap Chart
Since January 22, 2001, Korea United Pharm's market cap has increased from 34.22B to 290.08B, an increase of 747.77%. That is a compound annual growth rate of 8.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 290.08B | 3.39% |
| Dec 30, 2025 | 280.57B | 4.73% |
| Dec 30, 2024 | 267.89B | -35.75% |
| Dec 28, 2023 | 416.97B | 18.68% |
| Dec 29, 2022 | 351.33B | -51.95% |
| Dec 30, 2021 | 731.24B | -28.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humedix | 359.66B |
| Yungjin Pharm. | 327.01B |
| Huons | 311.10B |
| JW Holdings | 287.83B |
| BNC Korea | 277.00B |
| CMG Pharmaceutical | 262.42B |
| HLB Pharmaceutical | 245.88B |
| Chong Kun Dang Holdings | 241.84B |